INVERNESS MEDICAL INNOVATIONS, INC. 2001 STOCK OPTION AND INCENTIVE PLAN NON- QUALIFIED STOCK OPTION AGREEMENT FOR U.S. EXECUTIVESNon-Qualified Stock Option Agreement • March 2nd, 2009 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances • Delaware
Pursuant to the Inverness Medical Innovations, Inc. 2001 Stock Option and Incentive Plan (the “Plan”) as amended through the date hereof, Inverness Medical Innovations, Inc. (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase, on or prior to the Expiration Date specified above, all or part of the number of Option Shares of Common Stock, par value $0.001 per share (the “Stock”) of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein (the “Agreement”) and in the Plan.
INVERNESS MEDICAL INNOVATIONS, INC. 2001 STOCK OPTION AND INCENTIVE PLAN INCENTIVE STOCK OPTION AGREEMENT FOR EXECUTIVESIncentive Stock Option Agreement • March 2nd, 2009 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances • Delaware
Pursuant to the Inverness Medical Innovations, Inc. 2001 Stock Option and Incentive Plan (the “Plan”) as amended through the date hereof, Inverness Medical Innovations, Inc. (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase, on or prior to the Expiration Date specified above, all or part of the number of Option Shares of Common Stock, par value $0.001 per share (the “Stock”) of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein (the “Agreement”) and in the Plan.
Amendment No. 3 to Distribution AgreementDistribution Agreement • March 2nd, 2009 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances
This Amendment No, 3 to Distribution Agreement (this “Amendment”) is effective on July 11, 2008 (“Amendment Date”), and is entered into between Inverness Medical Innovations North America, Inc., a Delaware corporation (“Inverness”) having a place of business at 30 South Keller Road. Orlando, Florida 32804 (as successor by assignment from Biosite Corporation effective April 1, 2008), and Fisher HealthCare, a Division of Fisher Scientific Company, L.L.C. (“FHC”), having a place of business at 9999 Veterans Memorial Drive, Houston, Texas 77038 and amends the Distribution Agreement between the parties dated January 1, 2006 (as amended, the “2006 Distribution Agreement”).
INVERNESS MEDICAL INNOVATIONS, INC. 2001 STOCK OPTION AND INCENTIVE PLAN NON- QUALIFIED STOCK OPTION AGREEMENT FOR NON-U.S. EXECUTIVESNon-Qualified Stock Option Agreement • March 2nd, 2009 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances • Delaware
Pursuant to the Inverness Medical Innovations, Inc. 2001 Stock Option and Incentive Plan (the “Plan”) as amended through the date hereof, Inverness Medical Innovations, Inc. (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase, on or prior to the Expiration Date specified above, all or part of the number of Option Shares of Common Stock, par value $0.001 per share (the “Stock”) of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein, including any country-specific terms and conditions set forth in any appendix hereto (the “Appendix”) (collectively, the “Agreement”), and in the Plan.
Amendment No 2B to Distribution Agreement2b to Distribution Agreement • March 2nd, 2009 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances
This Amendment No. 2B to Distribution Agreement is entered into effective as of July 8, 2008 (“Amendment Date”) between Inverness Medical Innovations North America, Inc. (“Inverness”), a Delaware corporation having a place of business at 30 South Keller Road, Orlando. Florida 32810 (as successor by assignment from Biosite Incorporated effective April 1, 2008), and Fisher HealthCare, a Division of Fisher Scientific Company, L.L.C. (“FHC”), having a place of business at 9999 Veterans Memorial Drive, Houston, Texas 77038 and amends the Distribution Agreement between the parties dated January 1, 2006 (as amended, the “2006 Distribution Agreement”).
Amendment No. 2 to Distribution AgreementDistribution Agreement • March 2nd, 2009 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances
This Amendment No. 2 to Distribution Agreement is entered Into effective as of June 30, 2008 (“Amendment Date”) between Inverness Medical Innovations North America, Inc. (“Inverness”), a Delaware corporation having a place of business at 30 South Keller Road, Orlando, Florida 32810 (as successor by assignment from Biosite Incorporated effective April 1, 2008), and Fisher Healthcare, a division of Fisher Scientific Company L.L.C (“FHC”), having a place of business at 9999 Veterans Memorial Drive, Houston, Texas 77038 and amends the Distribution Agreement between the parties dated January 1, 2006 (as amended, the “2006 Distribution Agreement”)
INVERNESS MEDICAL INNOVATIONS, INC.Non-Qualified Stock Option Agreement • March 2nd, 2009 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances
Pursuant to the Inverness Medical Innovations, Inc. 2001 Stock Option and Incentive Plan (the “Plan”) as amended through the date hereof, Inverness Medical Innovations, Inc. (the “Company”) hereby grants to the Optionee named above, who is a member of the Board of Directors of the Company (a “Director”) but is not an employee of the Company, an option (the “Stock Option”) to purchase, on or prior to the Expiration Date specified above, all or part of the number of Option Shares of Common Stock, par value $0.001 per share (the “Stock”) of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan.
AMENDMENT NO. 1 TO DISTRIBUTION AGREEMENTDistribution Agreement • March 2nd, 2009 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances
THIS AMENDMENT NO. 1 TO DISTRIBUTION AGREEMENT (this “Amendment No. 1”), effective as of January 1, 2006 (the “Amendment Effective Date”), is entered into between FISHER SCIENTIFIC COMPANY L.L.C., a Delaware limited liability company represented by its FISHER HEALTHCARE division, (“FHC”), having a place of business at 9999 Veterans Memorial Drive, Houston, Texas 77038, and BIOSITE INCORPORATED, a Delaware corporation (“Biosite”), having a place of business at 9975 Summers Ridge Road, San Diego, California 92121. Capitalized terms not defined herein shall have the meanings set given to them in the Agreement.
